Analysts Set Expectations for UnitedHealth Group Inc’s Q4 2017 Earnings (UNH)
UnitedHealth Group Inc (NYSE:UNH) – Analysts at Leerink Swann upped their Q4 2017 earnings per share estimates for shares of UnitedHealth Group in a note issued to investors on Wednesday. Leerink Swann analyst A. Gupte now anticipates that the healthcare conglomerate will post earnings per share of $2.52 for the quarter, up from their prior estimate of $2.40. Leerink Swann currently has a “Hold” rating and a $210.00 price objective on the stock.
Other equities research analysts have also issued research reports about the stock. Argus reaffirmed a “buy” rating and issued a $170.00 target price on shares of UnitedHealth Group in a report on Monday, January 23rd. Jefferies Group LLC reaffirmed a “buy” rating and issued a $186.00 target price on shares of UnitedHealth Group in a report on Tuesday, January 10th. Barclays PLC reaffirmed a “buy” rating and issued a $187.00 target price on shares of UnitedHealth Group in a report on Monday, January 9th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $177.00 target price on the stock in a report on Wednesday, February 22nd. Finally, Vetr lowered shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Friday, February 10th. One research analyst has rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. The company has an average rating of “Buy” and an average price target of $181.05.
UnitedHealth Group (NYSE:UNH) traded down 0.26% on Friday, hitting $171.09. 1,630,856 shares of the stock traded hands. The stock has a 50-day moving average of $167.19 and a 200-day moving average of $157.47. UnitedHealth Group has a 12-month low of $128.53 and a 12-month high of $172.62. The firm has a market cap of $162.73 billion, a price-to-earnings ratio of 23.60 and a beta of 0.68.
This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/04/21/analysts-set-expectations-for-unitedhealth-group-incs-q4-2017-earnings-unh.html
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.17 by $0.20. The company earned $48.72 billion during the quarter, compared to the consensus estimate of $48.21 billion. UnitedHealth Group had a net margin of 3.92% and a return on equity of 21.20%. The company’s revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.81 EPS.
In related news, Director Michele J. Hooper sold 15,000 shares of the stock in a transaction that occurred on Thursday, March 16th. The shares were sold at an average price of $170.89, for a total value of $2,563,350.00. Following the sale, the director now directly owns 35,941 shares in the company, valued at approximately $6,141,957.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,310 shares of the stock in a transaction that occurred on Thursday, February 23rd. The shares were sold at an average price of $162.31, for a total transaction of $861,866.10. Following the completion of the sale, the director now owns 60,175 shares in the company, valued at $9,767,004.25. The disclosure for this sale can be found here. Insiders sold a total of 35,310 shares of company stock worth $5,855,416 over the last quarter. 1.65% of the stock is currently owned by corporate insiders.
Hedge funds have recently made changes to their positions in the stock. Oakworth Capital Inc. increased its stake in shares of UnitedHealth Group by 1.5% in the third quarter. Oakworth Capital Inc. now owns 4,261 shares of the healthcare conglomerate’s stock worth $597,000 after buying an additional 62 shares in the last quarter. Cypress Asset Management Inc. TX increased its stake in shares of UnitedHealth Group by 5.2% in the third quarter. Cypress Asset Management Inc. TX now owns 3,050 shares of the healthcare conglomerate’s stock worth $427,000 after buying an additional 150 shares in the last quarter. Strategic Advisors LLC increased its stake in shares of UnitedHealth Group by 2.8% in the third quarter. Strategic Advisors LLC now owns 2,203 shares of the healthcare conglomerate’s stock worth $308,000 after buying an additional 59 shares in the last quarter. Alpha Cubed Investments LLC increased its stake in shares of UnitedHealth Group by 0.9% in the third quarter. Alpha Cubed Investments LLC now owns 11,155 shares of the healthcare conglomerate’s stock worth $1,562,000 after buying an additional 96 shares in the last quarter. Finally, IFC Holdings Incorporated FL increased its stake in shares of UnitedHealth Group by 5.7% in the third quarter. IFC Holdings Incorporated FL now owns 30,988 shares of the healthcare conglomerate’s stock worth $4,349,000 after buying an additional 1,665 shares in the last quarter. Institutional investors and hedge funds own 86.67% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.